Leukemia, Lymphoma, Myeloma Cancer News |Hematologic & Blood

Hematologic Cancers News


Hematologic Cancers News

Selecting therapies for patients with multiple myeloma is challenging because the disease is inheren

Patient Preferences Explored in Multiple Myeloma Treatment

An Eastern Cooperative Oncology Group (ECOG) performance status of ≥2 is linked to lower treatment satisfaction in patients with relapsed or refractory multiple myeloma (RRMM), but receiving medication orally is linked to higher satisfaction.
Next post in Chronic Lymphocytic Leukemia